Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308802 · ClinicalTrials.gov registry record
Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 280
- Enrollment target
NCT00308802: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00308802 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 280 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00308802 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 280 participants
- Enrollment target
Study Summary
The purpose of this study is to test noninvasive methods to monitor the health and condition of new kidneys in people who have received kidney transplants.
Interventions
- PROCEDURE Kidney transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2006-03 |
| Est. Completion | 2011-07 |
What the finished NCT00308802 record still lists
NCT00308802 is an observational study that tracks outcomes without assigning an intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Kidney transplantation is the first listed.
NCT00308802 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00308802 about?
NCT00308802 is a clinical study titled "Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients". The purpose of this study is to test noninvasive methods to monitor the health and condition of new kidneys in people who have received kidney transplants.
What is the current status of trial NCT00308802?
This trial is currently completed. The enrollment target is 280 participants. The study started on 2006-03. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00308802?
The interventions under investigation include: Kidney transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT00308802?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04084730 · 280 participants · Phase 2
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- NCT04518657 · 280 participants · NA
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
- NCT04634916 · 280 participants · NA
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- NCT04829617 · 280 participants · NA
Promoting Well-being and Health in Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia